The genus Mycobacteria comprises a multitude of species known to cause serious disease in humans, including Mycobacterium tuberculosis and M. leprae, the responsible agents for tuberculosis and leprosy, respectively. In addition, there is a worldwide spike in the number of infections caused by a mixed group of species such as the M. avium, M. abscessus and M. ulcerans complexes, collectively called nontuberculous mycobacteria (NTMs). The situation is forecasted to worsen because, like tuberculosis, NTMs either naturally possess or are developing high resistance against conventional antibiotics. It is, therefore, important to implement and develop models that allow us to effectively examine the fundamental questions of NTM virulence, as well as to apply them for the discovery of new and improved therapies. This literature review will focus on the known molecular mechanisms behind drug resistance in NTM and the current models that may be used to test new effective antimicrobial therapies.
The genus Mycobacteria comprises a multitude of species known to cause serious disease in n class="Species">humans, including n>n class="Species">Mycobacterium tuberculosis and M. leprae, the responsible agents for tuberculosis and leprosy, respectively. In addition, there is a worldwide spike in the number of infections caused by a mixed group of species such as the M. avium, M. abscessus and M. ulcerans complexes, collectively called nontuberculous mycobacteria (NTMs). The situation is forecasted to worsen because, like tuberculosis, NTMs either naturally possess or are developing high resistance against conventional antibiotics. It is, therefore, important to implement and develop models that allow us to effectively examine the fundamental questions of NTM virulence, as well as to apply them for the discovery of new and improved therapies. This literature review will focus on the known molecular mechanisms behind drug resistance in NTM and the current models that may be used to test new effective antimicrobial therapies.
Entities:
Keywords:
antimicrobial testing; drug discovery; drug resistance mechanisms; nontuberculous mycobacteria
Authors: R Pandey; L Chen; C Manca; S Jenkins; L Glaser; C Vinnard; G Stone; J Lee; B Mathema; E L Nuermberger; R A Bonomo; B N Kreiswirth Journal: mBio Date: 2019-02-12 Impact factor: 7.786
Authors: Anna Rominski; Bettina Schulthess; Daniel M Müller; Peter M Keller; Peter Sander Journal: J Antimicrob Chemother Date: 2017-11-01 Impact factor: 5.790
Authors: Oxana Kazakova; Roxana Racoviceanu; Anastasiya Petrova; Marius Mioc; Adrian Militaru; Lucreția Udrescu; Mihai Udrescu; Adrian Voicu; Jason Cummings; Gregory Robertson; Diane J Ordway; Richard A Slayden; Codruța Șoica Journal: Int J Mol Sci Date: 2021-11-21 Impact factor: 5.923
Authors: Xiang Li; Jing Yang; Lianhua Zhang; Guangjie Jin; Li Xu; Fujin Fang; Yunhui Li; Pingmin Wei Journal: Int J Environ Res Public Health Date: 2022-07-06 Impact factor: 4.614